Literature DB >> 12351459

Variations in insulin secretion in carriers of the E23K variant in the KIR6.2 subunit of the ATP-sensitive K(+) channel in the beta-cell.

Leen M 't Hart1, Timon W van Haeften, Jacqueline M Dekker, Martine Bot, Robert J Heine, J Antonie Maassen.   

Abstract

An association between type 2 diabetes and genetic variation in the KIR6.2 gene has been reported in several populations. Based on in vitro studies with cell lines expressing the Glu(23)Lys (E23K) mutation, it was recently suggested that this mutation might result in altered insulin secretion. We have examined glucose-stimulated insulin secretion in relation to this KIR6.2 gene variant in two independent Dutch cohorts. Subjects with normal (n = 65) or impaired (n = 94) glucose tolerance underwent 3-h hyperglycemic clamps at 10 mmol/l glucose. We did not observe significant differences in first- or second-phase insulin secretion between carriers and noncarriers of the gene variant in either of the study populations (all P > 0.45). Furthermore, we found no evidence for a significant interaction with disease-associated gene variants in the sulfonylurea receptor (SUR1) gene. We conclude that the E23K mutation in the KIR6.2 gene is not associated with detectable alterations in glucose-stimulated insulin secretion in two independent populations from the Netherlands.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351459     DOI: 10.2337/diabetes.51.10.3135

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

Review 1.  Sulphonylurea action revisited: the post-cloning era.

Authors:  F M Gribble; F Reimann
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

2.  Quantitative traits associated with the Type 2 diabetes susceptibility allele in Kir6.2.

Authors:  M N Weedon; A L Gloyn; T M Frayling; A T Hattersley; G Davey Smith; Y Ben-Shlomo
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

Review 3.  Molecular defects in insulin secretion in type-2 diabetes.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 4.  Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes.

Authors:  Michael J Riedel; Diana C Steckley; Peter E Light
Journal:  Hum Genet       Date:  2004-11-23       Impact factor: 4.132

5.  The Genetic Basis of Type 2 Diabetes.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Cellscience       Date:  2006-04-30

Review 6.  Obstacles to Translating Genotype-Phenotype Correlates in Metabolic Disease.

Authors:  Anu Sharma; Adrian Vella
Journal:  Physiology (Bethesda)       Date:  2017-01

7.  Effect of genetic polymorphisms on the development of secondary failure to sulfonylurea in egyptian patients with type 2 diabetes.

Authors:  Alaa E El-Sisi; Sahar K Hegazy; Shereen S Metwally; Alaa M Wafa; Naglaa A Dawood
Journal:  Ther Adv Endocrinol Metab       Date:  2011-08       Impact factor: 3.565

Review 8.  Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis.

Authors:  Jerod Scott Denton; David Aaron Jacobson
Journal:  Trends Endocrinol Metab       Date:  2011-11-29       Impact factor: 12.015

9.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01

10.  Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps.

Authors:  Leen M 't Hart; Annemarie M Simonis-Bik; Giel Nijpels; Timon W van Haeften; Silke A Schäfer; Jeanine J Houwing-Duistermaat; Dorret I Boomsma; Marlous J Groenewoud; Erwin Reiling; Els C van Hove; Michaela Diamant; Mark H H Kramer; Robert J Heine; J Antonie Maassen; Kerstin Kirchhoff; Fausto Machicao; Hans-Ulrich Häring; P Eline Slagboom; Gonneke Willemsen; Elisabeth M Eekhoff; Eco J de Geus; Jacqueline M Dekker; Andreas Fritsche
Journal:  Diabetes       Date:  2009-10-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.